| 产品名称： | Staphylococcus aureus subsp. aureus Rosenbach |
|---|---|
| 商品货号： | TS154731 |
| Deposited As： | Staphylococcus aureus Rosenbach |
| Strain Designations： | 12478 |
| Application： | Drug discovery |
| Isolation： | Blood culture via central line, Human, Port Chester, New York, 1997 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genotype： | pvl negative |
| Type Strain： | no |
| Antibiotic Resistance： | Methicillin resistant Reduced vancomycin susceptibility |
| Comments： | Atypical phenotype characteristics MRSA SCCmec: Type II spa type Ridom: t002 spa type Kreiswirth: TJMBMDMGMK pvl gene amplification: Negative Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research. |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | SS Rotun, DM Myvett |
| Special Collection： | NCRR Contract |
| Year of Origin： | 1997 |
| References： | Rotun SS, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg. Infect. Dis. 5: 147-149, 1999. PubMed: 10081683 Dorla M Myvett, personal communication Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Staphylococcus aureus subsp. aureus Rosenbach |
|---|---|
| 商品货号： | TS154731 |
| Deposited As： | Staphylococcus aureus Rosenbach |
| Strain Designations： | 12478 |
| Application： | Drug discovery |
| Isolation： | Blood culture via central line, Human, Port Chester, New York, 1997 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genotype： | pvl negative |
| Type Strain： | no |
| Antibiotic Resistance： | Methicillin resistant Reduced vancomycin susceptibility |
| Comments： | Atypical phenotype characteristics MRSA SCCmec: Type II spa type Ridom: t002 spa type Kreiswirth: TJMBMDMGMK pvl gene amplification: Negative Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research. |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | SS Rotun, DM Myvett |
| Special Collection： | NCRR Contract |
| Year of Origin： | 1997 |
| References： | Rotun SS, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg. Infect. Dis. 5: 147-149, 1999. PubMed: 10081683 Dorla M Myvett, personal communication Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333 |
